Toxicity, mutation frequency and mutation spectrum induced by dacarbazine in CHO cells expressing different levels of O6-methylguanine-DNA methyltransferase-Reference-Cited by-同舟云学术

Toxicity, mutation frequency and mutation spectrum induced by dacarbazine in CHO cells expressing different levels of O6-methylguanine-DNA methyltransferase

Published:2000-02 Issue:2 Volume:447 Page:257-265
ISSN:0027-5107
Container-title:Mutation Research/Fundamental and Molecular Mechanisms of Mutagenesis
language:en
Short-container-title:Mutation Research/Fundamental and Molecular Mechanisms of Mutagenesis

Author:

Psaroudi Maria C.,Kyrtopoulos Soterios A.

Publisher

Elsevier BV

Subject

Health, Toxicology and Mutagenesis,Genetics,Molecular Biology

Reference23 articles.

1. Evolution in the treatment strategy of Hodgkin's disease;Bonadonna;Adv. Cancer Res.,1982

2. Absence of treatment-induced second neoplasma after ABVD in Hodgkin's disease;Valagussa;Blood,1982

3. In vitro mutagenic activity of DTIC in eukariotic and procariotic cells;Bartolli-Klugmann;Carcinogenesis,1982

4. International Agency for Research on Cancer Monoraphs on the Evaluation of the Carcinogenic Risk of Chemicals to Humans, IARC Lyon, Vol. 29, 1982, pp. 1–292.

5. Mechanisms of 5-(3,3-dimethyl-1-trizeno)imidazole-4-carboxamide (dacarbazine) cytotoxicity toward CHO cells in vitro are dictated by incubation conditions;Saunders;Chem. Biol. Interact.,1986

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. DNA direct repair pathways in cancer;AIMS Medical Science;2018

2. Dacarbazine;Encyclopedia of Toxicology;2014

3. Analysis of genotoxic damage induced by dacarbazine: an in vitro study;Toxin Reviews;2010-10-06

4. Modes of actions of two types of anti-neoplastic drugs, dacarbazine and ACNU, to induce apoptosis;Carcinogenesis;2007-09-04

5. The L84F polymorphism in the O 6 -Methylguanine-DNA-Methyltransferase (MGMT) gene is associated with increased hypoxanthine phosphoribosyltransferase (HPRT) mutant frequency in lymphocytes of tobacco smokers;Pharmacogenetics and Genomics;2007-09